Proscizen is a life sciences intelligence, analytics, and consulting firm helping organizations navigate the complexity of the global pharmaceutical, biotech, MedTech, and healthcare services landscape. Since 2008, we have been supporting decision-makers with accurate, curated, and forward-looking intelligence that enables smarter strategy, stronger partnerships, and sustained growth.
In an industry where change is constant—pipelines evolve, regulations shift, competition intensifies, and partnerships redefine value—reliable intelligence is no longer optional. It is foundational. Proscizen exists to ensure that organizations are not just informed, but prepared.
At Proscizen, we combine human expertise, proprietary data assets, and advanced analytics to deliver intelligence that goes beyond surface-level information. Our work spans the entire life sciences value chain—from early-stage drug discovery to commercialization, from clinical research to manufacturing, and from market strategy to investment decision-making.
We maintain and continuously evolve a robust intelligence ecosystem that includes proprietary databases, real-time industry monitoring, custom research, and bespoke analytics. Our solutions are designed to support business development, strategy, sales, competitive intelligence, licensing, and investment teams with clarity and confidence.
Rather than offering generic data products, we focus on context-rich intelligence—information that explains why something is happening, what it means, and what actions it enables.
Proscizen partners with a diverse set of organizations across the life sciences ecosystem. Our clients include pharma and biotech innovators, CROs, CDMOs, MedTech companies, consulting firms, intelligence platforms, and financial institutions.
While their objectives differ, they share a common need: trusted intelligence that supports high-stakes decisions. Whether identifying the right partners, evaluating competitive threats, assessing pipelines, or validating investment theses, our clients rely on Proscizen as a long-term intelligence partner—not just a data provider.
Life sciences decisions are rarely simple. They involve long timelines, regulatory uncertainty, scientific risk, and significant capital. Proscizen is built to operate in this complexity.
Comprehensive company intelligence and pipeline tracking
Track clinical trials, regulatory approvals, and manufacturing activity
Monitor partnerships, M&A, licensing, and funding trends
Identify emerging opportunities and competitive dynamics
These datasets can be accessed as structured intelligence products or extended through custom builds and consulting engagements, depending on client needs.
We believe that accurate intelligence accelerates innovation, improves collaboration, and ultimately contributes to better healthcare outcomes. By enabling organizations to see the full picture—past, present, and future—we help them focus on what truly matters.
Since 2008, Proscizen has remained focused on one domain: life sciences. This singular focus has allowed us to build deep expertise, trusted data assets, and long-standing client relationships across global markets.
not a cross-industry approach
not repackaged public data
supported by technology and AI
from data access to full consulting
As the life sciences industry continues to evolve, Proscizen will continue to invest in new data assets, advanced analytics, and domain expertise. Our goal remains the same as it was in 2008: to be a trusted intelligence partner that helps organizations move forward with clarity, confidence, and conviction.